MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2025 International Congress

    Functional Alterations in Early-Stage Parkinson’s Disease and Multiple System Atrophy with REM Sleep Behavior Disorder

    SC. Wang, Y. Xiao, YB. Hou, CY. Li, RW. Ou, JY. Lin, TM. Yang, NN. Che, QR. Jiang, XT. Zheng, JY. Liu, HF. Shang (Chengdu, Sichuan, China)

    Objective: This study investigated functional brain network alterations in early-stage Parkinson’s disease (PD) and multiple system atrophy (MSA) patients with probable rapid eye movement sleep…
  • 2025 International Congress

    Brain perfusion patterns associated with motor symptoms in multiple system atrophy

    Y. Nakano, A. Sugiyama, S. Hirano, Y. Nakagawa, M. Tamura, T. Yamamoto, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, S. Kuwabara, Y. Kitayama (Chiba, Japan)

    Objective: There is a need for objective methods to assess disease progression in multiple system atrophy (MSA). This study aimed to identify brain perfusion patterns…
  • 2025 International Congress

    The Role of FGF14 GAA Repeat Expansions in Multiple System Atrophy: Frequency, Phenotypic Correlations, and Prognostic Implications

    V. Chelban, D. Pellerin, N. Vijiaratnam, S. Sambin, M. Ostrozovicova, C. Girges, P. Leigh, L. Beichert, C. Bonnet, M. Renaud, W. Meissner, A. Sieben, D. Crosiers, P. Cras, S. Zuchner, J-C. Corvol, M. Farrer, M. Synofzik, B. Brais, T. Warner, H. Morris, Z. Jaunmuktane, T. Foltynie, H. Houlden (London, United Kingdom)

    Objective: This study aimed to investigate the frequency of FGF14 GAA•TTC repeat expansion in clinically diagnosed and pathologically confirmed multiple system atrophy cases. Background: Partial…
  • 2025 International Congress

    Retrospective analysis of MSA diagnosis in a neuroscience hospital

    M. Wazil, M. Farhan Abdulla, J. Mitchell, D. Damodaran (Liverpool, United Kingdom)

    Objective: We evaluated the extent to which diagnoses of MSA align with the MDS criteria within a specialist neurology trust in the UK. We aimed…
  • 2025 International Congress

    Novel Multiple System Atrophy Subtypes Identified Using Unsupervised Machine Learning Algorithms

    H. Sekiya, D. Ono, A. Maier, D. Dickson (Jacksonville, USA)

    Objective: To identify a novel disease subtype of multiple system atrophy (MSA) by applying machine learning algorithms to a large cohort of autopsy-confirmed MSA. Background:…
  • 2025 International Congress

    Natural history and epidemiological study of multiple system atrophy in Hokkaido: HoRC-MSA 2014-2025

    M. Matsushima, K. Sakushima, Y. Kanatani, N. Nishimoto, J. Sawada, T. Matsuoka, H. Uesugi, N. Minami, K. Sako, A. Takei, S. Hisahara, A. Tamakoshi, N. Sato, I. Yabe (Sapporo, Japan)

    Objective: To investigate epidemiological information of multiple system atrophy (MSA) patients in Hokkaido, Japan by using the registry data from the Hokkaido Rare-disease Consortium for…
  • 2025 International Congress

    Intrathecal Administration of Human Oral Mucosa Neural Crest Stem Cells in Moderate/Advanced Multiple System Atrophy: Report on Ongoing Phase 1 Study

    T. Gurevich, V. Livneh, O. Aizenstein, M. Artzi, A. Ezra, H. Shabtai, H. Rachima, A. Shuster, B. Koren, H. Goltsman, S. Pitaru (Tel Aviv, Israel)

    Objective: This first-in-human study aims to evaluate the safety of hOMNSC300 following intrathecal administration in patients with moderate to advanced MSA. Background: Stem cell therapy…
  • 2025 International Congress

    Longitudinal FDG-PET Study of Metabolic Trajectories and Connectivity Alterations in Multiple System Atrophy

    Y. Zhao, H. Lin, X. Li, F. Liu, J. Wang (Shanghai, China)

    Objective: 本研究使用 FDG-PET 探索 MSA 中葡萄糖代谢和网络连接的纵向变化,以辅助早期诊断和监测疾病进展。 Background: Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease with distinct metabolic patterns in its parkinsonian (MSA-P)…
  • 2025 International Congress

    Neurogenic bladder and affective disorders in parkinsonism

    E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)

    Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA. Background: In the group of patients with extrapyramidal pathology…
  • 2025 International Congress

    Balance confidence may not accurately assess fall risk in atypical parkinsonism

    G. Arleth, E. Buxton, R. Bryant, M. Ivancic, N. Browner, J. Shurer, M. Sklerov (Chapel Hill, USA)

    Objective: Objective: To examine if balance confidence, measured by the Activities-specific Balance Confidence (ABC) scale, reflects fall frequency in atypical parkinsonian syndromes (APS), namely multiple…
  • 1
  • 2
  • 3
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley